Fang G X, Chan P C, Cheng I K, Li M K, Wong K K, Chan M K
Department of Medicine, University of Hong Kong.
Int Urol Nephrol. 1990;22(2):181-7. doi: 10.1007/BF02549838.
Haematological changes after renal transplantation in 76 patients were reviewed and the differences observed between patients treated with cyclosporin-A and prednisolone and those treated with azathioprine and prednisolone were compared. Erythrocytosis defined as haemoglobin concentration equal to or exceeding 17 g/dl occurred in 25% of patients treated with cyclosporin-A and in 11.4% of patients treated with azathioprine. Only one patient, who received cyclosporin-A, had clinical evidence of thrombosis. Eight patients treated with cyclosporin-A and five treated with azathioprine had therapeutic venesections. There was no difference in the incidence of putative risk factors for post-transplant erythrocytosis between the two groups.
回顾了76例肾移植患者的血液学变化,并比较了接受环孢素A和泼尼松龙治疗的患者与接受硫唑嘌呤和泼尼松龙治疗的患者之间观察到的差异。红细胞增多症定义为血红蛋白浓度等于或超过17g/dl,在接受环孢素A治疗的患者中发生率为25%,在接受硫唑嘌呤治疗的患者中发生率为11.4%。仅1例接受环孢素A治疗的患者有血栓形成的临床证据。8例接受环孢素A治疗的患者和5例接受硫唑嘌呤治疗的患者接受了治疗性静脉放血。两组之间移植后红细胞增多症假定危险因素的发生率没有差异。